Pre-market charges for medical device firms
The Irish Medicines Board wants the Government to impose the rule change by 2015 to prevent another DePuy hips or PIPs breast implant crisis — and ensure the public does not have to pay to resolve future problems.
Speaking at an Oireachtas Health Committee meeting, the independent watchdog’s chief executive, Pat O’Mahony, said the controversies — which damaged thousands of patients in Ireland — must not be repeated.